Crystalline Porphyrazine-Linked Fused Aromatic Networks with High Proton Conductivity.

Fused aromatic networks (FANs) have been studied in efforts to overcome the low physicochemical stability of metal-organic frameworks (MOFs) and covalent organic frameworks (COFs), while preserving crystallinity. Herein, we describe the synthesis of a highly stable and crystalline FAN (denoted as Pz-FAN) using pyrazine-based building blocks to form porphyrazine (Pz) linkages via an irreversible reaction. Unlike most COFs and FANs, which are synthesized from two different building blocks, the new Pz-FAN is formed using a single building block by self-cyclotetramerization. Controlled and optimized reaction conditions result in a highly crystalline Pz-FAN with physicochemical stability. The newly prepared Pz-FAN displayed a high magnitude (1.16×10-2  S cm-1 ) of proton conductivity compared to other reported FANs and polymers. Finally, the Pz-FAN-based membrane was evaluated for a proton-exchange membrane fuel cell (PEMFC), which showed maximum power and current densities of 192 mW cm-2 and 481 mA cm-2 , respectively.

Quenching Epigenetic Drug Resistance Using Antihypoxic Microparticles in Glioblastoma Patient-Derived Chips.

Glioblastoma (GBM) is one of the most intractable tumor types due to the progressive drug resistance upon tumor mass expansion. Incremental hypoxia inside the growing tumor mass drives epigenetic drug resistance by activating nongenetic repair of antiapoptotic DNA, which could be impaired by drug treatment. Hence, rescuing intertumor hypoxia by oxygen-generating microparticles may promote susceptibility to antitumor drugs. Moreover, a tumor-on-a-chip model enables user-specified alternation of clinic-derived samples. This study utilizes patient-derived glioblastoma tissue to generate cell spheroids with size variations in a 3D microchannel network chip (GBM chip). As the spheroid size increases, epigenetic drug resistance is promoted with inward hypoxia severance, as supported by the spheroid size-proportional expression of hypoxia-inducible factor-1a in the chip. Loading antihypoxia microparticles onto the spheroid surface significantly reduces drug resistance by silencing the expression of critical epigenetic factor, resulting in significantly decreased cell invasiveness. The results are confirmed in vitro using cell line and patient samples in the chip as well as chip implantation into a hypoxic hindlimb ischemia model in mice, which is an unprecedented approach in the field.